Successful Use of Factor VIIa to Control Life-threatening Post-operative Haemorrhage in a Patient on Extra-Corporeal Membrane Oxygenation

Heart Lung and Circulation

Volumn 21, Issue 4, 2012, Pages 229-230

  Dunne, Ben ^a   Xiao, Peter ^a   Andrews, David ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

Cardiac surgery; Coagulopathy; ECMO; Extracorporeal membrane oxygenation; Factor seven; Haemorrhage

Indexed keywords

CALCIUM ION; CLOPIDOGREL; FIBRINOGEN; FRESH FROZEN PLASMA; RECOMBINANT BLOOD CLOTTING FACTOR 7A; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; CORONARY ARTERY BYPASS GRAFT; CRYOPRECIPITATE; ERYTHROCYTE TRANSFUSION; EXTRACORPOREAL OXYGENATION; HEART TRANSPLANTATION; HEPARINIZATION; HUMAN; HYPOTHERMIA; INTERNATIONAL NORMALIZED RATIO; ISCHEMIC CARDIOMYOPATHY; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PH; POSTOPERATIVE HEMORRHAGE; PRIMARY GRAFT DYSFUNCTION; PRIORITY JOURNAL; PROTHROMBIN TIME; PULMONARY HYPERTENSION; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; TISSUE ADHESION;

COAGULANTS; DELAYED GRAFT FUNCTION; EXTRACORPOREAL MEMBRANE OXYGENATION; FACTOR VIIA; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE;

EID: 84858288950     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2011.09.007     Document Type: Article

References (15)

1. Zangrillo A., Mizzi A., Biondi-Zoccai G. Recombinant activated factor VII in cardiac surgery: a meta-analysis. J Thorac Cardiovacs Anaesth 2009, 23:34-40.
2. Gill R., Herbertson M., Vuylsteke A. Safety and efficacy of recombinant activated factor VII. A randomized placebo-controlled trial in the setting of bleeding after cardiac surgery. Circulation 2009, 120:21-27.
3. Kharkouti K., Beattie W., Wijeysundera D. Recombinant factor VII for intractable blood loss after cardiac surgery: a propensity score-matched case-control analysis. Transfusion 2005, 45:26-34.
4. McCall P., Story D. Audit of factor VIIa for bleeding resistant to conventional therapy following complex cardiac surgery. Can J Anaesth 2006, 53:926-933.
5. Raivio P., Suojaranta-Ylinen R. Recombinant factor VIIa in the treatment of postoperative haemorrhage after cardiac surgery. Ann Thorac Surg 2005, 80:66-71.
6. Warren O., Mandal K. Recombinant activated factor VII in cardiac surgery: a systematic review. Ann Thorac Surg 2007, 83:707-714.
7. Despotis G., Eby C. A review of transfusion risks and optimal management of perioperative bleeding with cardiac surgery. Transfusion 2008, 48:2S-30S.
8. Isbister J., Phillips L. Recombinant activated factor VII in critical bleeding: experience from the Australian and New Zealand Haemostasis Register. Intern Med J 2008, 38:156-165.
9. Romagnoli S., Bevilacqua S. Small-dose recombinant activated factor VII (Novoseven) in cardiac surgery. Anaesth Analg 2006, 102:1320-1326.
10. O'Connell K., Wood J. Thrombo-embolic adverse events after use of recombinant human coagulation factor VIIa. JAMA 2006, 295:293-298.
11. Syburra T., Lachat M. Fatal outcome of recombinant factor VIIa in heart transplantation. Ann Thorac Surg 2010, 89:1643-1645.
12. Swaminathan M., Shaw A. Fatal thrombosis after factor VII administration during extracorporeal membrane oxygenation. J Cardiothorac Vasc Anesth 2008, 22(2):259-260.
13. Bui J., Despotis G. Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 2002, 124:852-854.
14. Brose S., Sirbu H. Successful use of recombinant factor VIIa in a patient with intractable bleeding. J Thorac Cardiovasc Surg 2005, 53:389-390.
15. Lucey M., Myburgh J. Recombinant activated factor VII for exsanguinating haemorrhage post bilateral lung transplantation. Anaesth Intensive Care 2003, 31:465-469.